Cerebellum’s NEVRO CORP. NVRO Stock Holding History

Cerebellum’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-756	Closed	-$47K	–	533
2019 Q1	$47K	Sell	756 -3,802	-83%	-$179K	0.04%	379
2018 Q4	$177K	Buy	+4,558	New	+$203K	0.12%	316

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cerebellum's NVRO Position: Q2 2019 in Review

Cerebellum sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 756 shares — an estimated $47K sold.

Cerebellum first reported a position in NVRO in Q4 2018 and held it in 2 quarters. The position peaked at $177K in Q4 2018. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

Cerebellum reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
Cerebellum sold 756 NEVRO CORP. shares in Q2 2019, an estimated $47K.
Cerebellum first reported a position in NEVRO CORP. in Q4 2018 and held it in 2 quarters.
Cerebellum's NEVRO CORP. position peaked at $177K in Q4 2018.
162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Cerebellum's 13F filing for Q2 2019, filed 19 Jul 2019.